A
REGN icon

AlphaQuest’s Regeneron Pharmaceuticals REGN Stock Holding History

AlphaQuest’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-662
Closed -$511K – 1614
2025
Q4 		$511K Sell
662
-1,188
-64% -$807K 0.03% 811
2025
Q3 		$1.04M Buy
1,850
+1,040
+128% +$588K 0.07% 409
2025
Q2 		$425K Sell
810
-1,275
-61% -$712K 0.04% 683
2025
Q1 		$1.32M Sell
2,085
-151
-7% -$104K 0.14% 205
2024
Q4 		$1.59M Buy
2,236
+262
+13% +$220K 0.21% 102
2024
Q3 		$2.08M Buy
1,974
+1,572
+391% +$1.75M 0.18% 130
2024
Q2 		$423K Sell
402
-589
-59% -$571K 0.06% 515
2024
Q1 		$954K Sell
991
-137
-12% -$130K 0.17% 202
2023
Q4 		$991K Buy
+1,128
New +$929K 0.21% 148

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AlphaQuest's REGN Position: Q1 2026 in Review

AlphaQuest sold out of Regeneron Pharmaceuticals (REGN) in Q1 2026, closing a stake of 662 shares — an estimated $511K sold.

AlphaQuest first reported a position in REGN in Q4 2023 and held it in 9 quarters. The position peaked at $2.08M in Q3 2024. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • AlphaQuest reported no remaining Regeneron Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 662 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $511K.
  • AlphaQuest first reported a position in Regeneron Pharmaceuticals in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Regeneron Pharmaceuticals position peaked at $2.08M in Q3 2024.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.